Pfizer Settles With Mylan Units Over Generic Vfend
Pfizer Inc. has laid down the sword with two Mylan Inc. subsidiaries over the pharmaceutical giant's anti-fungal medication Vfend, agreeing to an out-of-court settlement and license agreement that will allow a...To view the full article, register now.
Already a subscriber? Click here to view full article